This COVID-19 roundup includes coverage on the outcomes associated with two omicron subvariant treatments, FDA’s authorization of Novavax vaccine, the NIH Treatment Guidelines Panel’s recommendation of...
Researchers evaluated the national trends in the United States to determine the frequency of anesthesia/sedation in pediatric patients undergoing CT or MRI in emergency departments.
The FDA approved the second over-the-counter nasal spray with the goal of increasing access to products that can rapidly reverse the effects of opioid overdose.
The Society for Academic Emergency Medicine has released the third guideline in their Guidelines for Reasonable and Appropriate Care in the Emergency Department series.
To guide prevention efforts for fatal poisonings in pediatric patients, the authors of a recent study examined characteristics of death from poisoning in young children within the United States.
The American College of Gastroenterology provided an update to their 2016 guidelines, providing physicians with tools and management strategies for patients with acute lower intestinal bleeding.
Following three studies that examined its safety and efficacy, the FDA approves the first fecal microbiota product to prevent recurring Clostridioides difficle infection in patients.
